Caplight Directory>Investors>Life Sciences at Goldman Sachs Alternatives>Life-sciences-at-goldman-sachs-alternatives


Life Sciences at Goldman Sachs Alternatives

Life Sciences at Goldman Sachs Alternatives

New York City, New Yorkgoldmansachs.com

Overview

Life Sciences at Goldman Sachs Alternatives is a private equity investor that focuses on growth-oriented investments in early- to mid-stage therapeutic, life sciences tools, and diagnostics companies. The strategy targets areas of innovation such as precision medicine, genetic medicine, cell therapy, and immunotherapy.

Year Founded

2021

Portfolio Companies

5

Investments

CompanyDateStageLead
SidewinderApr 2026Series BCo-investor
Sidewinder TherapeuticsApr 2026Series BCo-investor
AirNexis TherapeuticsMar 2026Series ACo-investor
AirNexis TherapeuticsJan 2026Series ACo-investor
Beacon TherapeuticsJan 2026Series CLead

Sector & Stage Mix

Industry, funding stage, and valuation band breakdowns.

Premium
SeedSeries ASeries BGrowth

Unlock portfolio analytics

Sign up to view full sector, stage, and valuation breakdowns for this investor.

Investment Activity

Yearly cadence, pace, and funding raised over time.

Premium
2021
2022
2023
2024
2025
2026

Unlock portfolio analytics

Sign up to explore yearly investment trends and funding raised over time.

FAQ

Firmographic Details

HeadquartersNew York City, New York
Year Founded2021

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.





Caplight Logo




Use CasesInvestorsEmployees

CompaniesAll Companies

LegalPrivacy PolicyTerms of UseBrokerCheckForm CRS


Disclaimer All investments involve risk, including the risk of loss of principal. You should carefully consider your investment objectives, risks, transaction costs and other expenses before deciding to invest in options, swaps or other investments.This does not constitute an offer by Caplight Technologies, Inc. to sell, or a solicitation of an offer to buy, any securities and may not be used or relied upon in connection with any offer or sale of securities. An offer or solicitation can be made only through the delivery of final offering document(s) and purchase agreement(s), and will be subject to the terms and conditions and risks delivered in such documents. Any securities offered are offered through Caplight Markets LLC, member FINRA/SIPC.